AbbVie Inc. (ABBV) stock price$293.42 · 761.01 ₾
One AbbVie Inc. share costs 293.42 dollars, or 761.01 lari at the National Bank rate. Price as of 10.11.2026 22:03; the market is open.
In short
10 November 2026- One AbbVie Inc. (ABBV) share costs $293.42, or 761.01 ₾. Day change: +0.04%.
- The price is at 92% of its 52-week range ($190.75 - $302.93).
- 31 of 38 analysts rate it a buy, average rating 4.1/5.
- Over the last 12 months the stock moved +32.99%.
- Next earnings report: 02.02.2027.
This is an automatic summary of prices, not investment advice.
Price in dollars
$293.42
Price in lari
761.01 ₾
Today's change
+0.04%
Dividend yield
4.47%
10.11.2026 22:03 · Market open · 1 $ = 2.5936 ₾ · National Bank · Methodology
Price history
…
Key figures
- 52-week range
- $190.75 - $302.93
- 52-week change
- +32.99%
- Market cap
- $514.6B
- P/E (trailing 12 months)
- 49.8
- Earnings per share (EPS)
- $5.83
- Beta (volatility vs market)
- 0.15
- Exchange
- NYSE
- Industry
- Biotechnology
- Next earnings report
- 02.02.2027, after the close
Figures: Finnhub, updated 10.11.2026
Dividend
- Dividend yield
- 4.47%
- Annual dividend per share
- $6.60 (17.11 ₾)
- Payout ratio
- 117.4%
- Dividend growth, 5-year average
- 6.8%
Yield = annual dividend / share price. Dividends are not guaranteed and can change. They are taxed: US companies withhold tax on dividends paid to non-residents.
Value of ABBV shares
| Shares | Lari | Dollars |
|---|---|---|
| 1 ABBV | 761.01 ₾ | $293.42 |
| 5 ABBV | 3,805.07 ₾ | $1,467.10 |
| 10 ABBV | 7,610.14 ₾ | $2,934.20 |
| 25 ABBV | 19,025.35 ₾ | $7,335.50 |
| 50 ABBV | 38,050.71 ₾ | $14,671.00 |
| 100 ABBV | 76,101.41 ₾ | $29,342.00 |
At the current price, without broker fees or the exchange-rate spread.
Recent closing prices
| Date | Price, $ | Price, ₾ |
|---|---|---|
| 10.11.2026 | 293.74 | 762.05 |
| 09.11.2026 | 293.13 | 760.64 |
| 06.11.2026 | 290.48 | 753.94 |
| 05.11.2026 | 289.00 | 750.19 |
| 04.11.2026 | 294.14 | 763.88 |
| 03.11.2026 | 286.00 | 742.83 |
| 02.11.2026 | 288.84 | 750.75 |
| 30.10.2026 | 294.89 | 765.50 |
| 29.10.2026 | 290.79 | 754.80 |
| 28.10.2026 | 285.99 | 742.43 |
| 27.10.2026 | 286.39 | 743.64 |
Analyst ratings: ABBV
Buy4.1 / 5
38 analysts, November 2026
- Strong buy10
- Buy21
- Hold7
- Sell0
- Strong sell0
How the view is changing
- November 2026
- October 2026
- September 2026
- August 2026
Earnings per share: estimate and actual
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q3 2026 | $3.82 | $3.82 | −0.08% missed |
| Q2 2026 | $3.68 | $3.65 | −0.71% missed |
| Q1 2026 | $2.65 | $2.65 | +0.18% beat |
| Q4 2025 | $2.71 | $2.71 | +0.17% beat |
This is the combined recommendation of analysts at US investment banks and brokers (source: Finnhub, updated monthly). It is not advice from GFX.GE.
How to buy AbbVie Inc. (ABBV) stock from Georgia
- 1Open an account with a licensed broker: a Georgian bank's brokerage or an international broker. Check who regulates it.
- 2Deposit money and convert it to dollars. Compare the broker's rate with the rates on GFX.GE: the gap adds straight to your cost.
- 3Search for the ticker ABBV and place an order: at the market price (market) or at a price you set (limit).
Full guide: costs, documents, tax
Are you a broker or an investing app?Your offer can go here: this page is read by people who are about to buy a stock.Contact usAbout the company
AbbVie is a biopharmaceutical company spun off from Abbott in 2013. It is known for immunology drugs (Skyrizi, Rinvoq, earlier Humira), oncology and aesthetics (Botox). It raises its dividend steadily.
Website: abbvie.com
FAQ: ABBV
How much is one AbbVie Inc. (ABBV) share in lari?
At the top of this page: ABBV's dollar price times the National Bank USD/GEL rate. Your real cost at a broker depends on fees and its exchange rate.
What is P/E?
P/E is the share price divided by the last 12 months' earnings per share. A high P/E means investors expect growth or the share is expensive. On its own it isn't enough to judge a stock.
Prices and figures are for information and come from Finnhub; ETF facts from issuers' pages. Lari values at the National Bank rate. This is not investment advice or a recommendation to buy or sell.